ALPRAZOLAM PLUS 2 ALP+ 2 V2 S SH

GUDID B800ALP2V2SSH0

ALPRAZOLAM PLUS 2

UTAK LABORATORIES, INC.

Multiple-type clinical chemistry analyte profile IVD, control

• Primary Device ID: B800ALP2V2SSH0
• NIH Device Record Key: 273829bb-9be6-420f-a715-d29a8d3dda59
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: ALPRAZOLAM PLUS 2
• Version Model Number: ALP+ 2 V2 S SH
• Catalog Number: ALP+ 2 V2 S SH
• Company DUNS: 092519016
• Company Name: UTAK LABORATORIES, INC.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: true
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: false
• OTC Over-The-Counter: false

Customer Support Contacts

• Phone: 1-888-882-5522
• Email: welovecontrol@utak.com
• Phone: 1-888-882-5522
• Email: welovecontrol@utak.com
• Phone: 1-888-882-5522
• Email: welovecontrol@utak.com

Device Dimensions

• Total Volume: 3 Milliliter
• Total Volume: 3 Milliliter
• Total Volume: 3 Milliliter

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius
• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
HIBCC	B800ALP2V2SSH0 [Primary]

FDA Product Code

• LAS: Drug Specific Control Materials

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2025-01-23
• Device Publish Date: 2025-01-15

Devices Manufactured by UTAK LABORATORIES, INC.

• B800ALP1V2SSH5 - ALPRAZOLAM PLUS 1: 2025-01-23 ALPRAZOLAM PLUS 1
• B800ALP2V2SSH0 - ALPRAZOLAM PLUS 2: 2025-01-23ALPRAZOLAM PLUS 2
• B800ALP2V2SSH0 - ALPRAZOLAM PLUS 2: 2025-01-23 ALPRAZOLAM PLUS 2
• B800IMIP1000SFUW5 - IMIPRAMINE 1000 NG/ML: 2025-01-22 IMIPRAMINE 1000 NG/ML
• B80091801UAL5 - BUPRENORPHINE HYDROLYSIS QC: 2025-01-21 BUPRENORPHINE HYDROLYSIS QC
• B800MDLABS43V2HIGH0 - MD LABS 43 DRUGS HIGH: 2025-01-21 MD LABS 43 DRUGS HIGH
• B800MDLABS43V2LOW5 - MD LABS 43 DRUGS LOW: 2025-01-21 MD LABS 43 DRUGS LOW
• B800DOA1EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 1: 2025-01-20 DRUGS OF ABUSE LEVEL 1
• B800DOA2EXTBUFOFFMMC5 - DRUGS OF ABUSE LEVEL 2: 2025-01-20 DRUGS OF ABUSE LEVEL 2